Meta-analysis on clinical efficacy of ringheaded thumbtack needle in the treatment of allergic rhinitis.

Q3 Medicine

针刺研究 Pub Date : 2024-05-25 DOI:10.13702/j.1000-0607.20230099

Shui-En He, Xi-Tao Ling, Yi-Ming Liu, Han-Hua Chen

{"title":"Meta-analysis on clinical efficacy of ringheaded thumbtack needle in the treatment of allergic rhinitis.","authors":"Shui-En He, Xi-Tao Ling, Yi-Ming Liu, Han-Hua Chen","doi":"10.13702/j.1000-0607.20230099","DOIUrl":null,"url":null,"abstract":"Objectives: To evaluate the efficacy and safety of ringheaded thrumbtack needle in the treatment of allergic rhinitis (AR).Methods: Clinical studies about treatment of AR with ringheaded thrumbtack needle were searched from databases of CNKI, Wanfang, China Science and Technology Journal, China Biology Medicine disc, PubMed, Embase and Web of Science from their inception to November 2022. Two researchers independently screened the literature and collected related information. The total effective rate, visual analogue scale (VAS) for AR, rhinoconjunctivitis quality of life questionnaire (RQLQ), and recurrence rate were the main outcome indicators. Secondary outcome indicators included quantitative scores of symptoms and signs, 'quartering' symptom evaluation scale, etc. All the included studies were subjected to Meta-analysis using Stata software.Results: A total of 22 clinical studies involving 1 491 participants were included. The results of Meta-analysis indicated that the total effective rate of ringheaded thrumbtack needle in the treatment of AR was higher than that of traditional Chinese and Western medicine ［RR=1.20, 95%CI (1.14, 1.26), P<0.001］, and recurrence rate is lower than conventional therapy ［OR=0.35, 95%CI (0.14, 0.89), P=0.027］. Moreover, The VAS score ［WMD=-1.30, 95%CI (-1.85, -0.75), P<0.001］ and RQLQ score ［WMD=-6.75, 95%CI (-12.74, -0.76), P=0.027］ of AR treated by ringheaded thrumbtack needle were lower than those of traditional Chinese and Western medicine.Conclusions: Ringheaded thrumbtack needle can improve the total effective rate, reduce the disease recurrence, and improve the symptoms of discomfort when AR outbreaks, and has no significant adverse reactions. However, the reliability is limited. Thus, it is still necessary to improve the level of evidence quality by including researches with large samples, rigorous design and international standards.","PeriodicalId":34919,"journal":{"name":"针刺研究","volume":"49 5","pages":"534-543"},"PeriodicalIF":0.0000,"publicationDate":"2024-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"针刺研究","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.13702/j.1000-0607.20230099","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: To evaluate the efficacy and safety of ringheaded thrumbtack needle in the treatment of allergic rhinitis (AR).

Methods: Clinical studies about treatment of AR with ringheaded thrumbtack needle were searched from databases of CNKI, Wanfang, China Science and Technology Journal, China Biology Medicine disc, PubMed, Embase and Web of Science from their inception to November 2022. Two researchers independently screened the literature and collected related information. The total effective rate, visual analogue scale (VAS) for AR, rhinoconjunctivitis quality of life questionnaire (RQLQ), and recurrence rate were the main outcome indicators. Secondary outcome indicators included quantitative scores of symptoms and signs, 'quartering' symptom evaluation scale, etc. All the included studies were subjected to Meta-analysis using Stata software.

Results: A total of 22 clinical studies involving 1 491 participants were included. The results of Meta-analysis indicated that the total effective rate of ringheaded thrumbtack needle in the treatment of AR was higher than that of traditional Chinese and Western medicine ［RR=1.20, 95%CI (1.14, 1.26), P<0.001］, and recurrence rate is lower than conventional therapy ［OR=0.35, 95%CI (0.14, 0.89), P=0.027］. Moreover, The VAS score ［WMD=-1.30, 95%CI (-1.85, -0.75), P<0.001］ and RQLQ score ［WMD=-6.75, 95%CI (-12.74, -0.76), P=0.027］ of AR treated by ringheaded thrumbtack needle were lower than those of traditional Chinese and Western medicine.

Conclusions: Ringheaded thrumbtack needle can improve the total effective rate, reduce the disease recurrence, and improve the symptoms of discomfort when AR outbreaks, and has no significant adverse reactions. However, the reliability is limited. Thus, it is still necessary to improve the level of evidence quality by including researches with large samples, rigorous design and international standards.

查看原文本刊更多论文

环头拇指针治疗过敏性鼻炎临床疗效的 Meta 分析。

目的：评估环头刺血针治疗过敏性鼻炎（AR）的有效性和安全性：评价环头刺吸针治疗过敏性鼻炎（AR）的有效性和安全性：方法：从CNKI、万方、中国科技期刊、中国生物医学文献数据库、PubMed、Embase和Web of Science等数据库中检索从开始到2022年11月有关环头刺血针治疗AR的临床研究。两名研究人员独立筛选文献并收集相关信息。主要结局指标包括总有效率、AR视觉模拟量表（VAS）、鼻结膜炎生活质量问卷（RQLQ）和复发率。次要结果指标包括症状和体征的量化评分、"四分之一 "症状评估量表等。所有纳入的研究均使用 Stata 软件进行 Meta 分析：结果：共纳入 22 项临床研究，涉及 1 491 名参与者。Meta分析结果显示，环跳针治疗AR的总有效率高于中西医治疗［RR=1.20, 95%CI (1.14, 1.26), POR=0.35, 95%CI (0.14, 0.89), P=0.027］。此外，环跳针治疗AR的VAS评分［WMD=-1.30, 95%CI (-1.85, -0.75)，PWMD=-6.75, 95%CI (-12.74, -0.76)，P=0.027］均低于中西医治疗：结论：环头刺血针可提高总有效率，减少疾病复发，改善AR发作时的不适症状，且无明显不良反应。但可靠性有限。因此，仍有必要通过纳入大样本、严谨设计和国际标准的研究来提高证据质量水平。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

针刺研究 Medicine-Medicine (all)

CiteScore

1.30

自引率

0.00%

发文量

期刊介绍： Acupuncture Research was founded in 1976. It is an acupuncture academic journal supervised by the State Administration of Traditional Chinese Medicine, co-sponsored by the Institute of Acupuncture of the China Academy of Chinese Medical Sciences and the Chinese Acupuncture Association. This journal is characterized by "basic experimental research as the main focus, taking into account clinical research and reporting". It is the only journal in my country that focuses on reporting the mechanism of action of acupuncture. The journal has been changed to a monthly journal since 2018, published on the 25th of each month, and printed in full color. The manuscript acceptance rate is about 10%, and provincial and above funded projects account for about 80% of the total published papers, reflecting the latest scientific research results in the acupuncture field and has a high academic level. Main columns: mechanism discussion, clinical research, acupuncture anesthesia, meridians and acupoints, theoretical discussion, ideas and methods, literature research, etc.